Side Effects of Drugs Annual 25, 25

A world-wide survey of new data and trends in adverse drug reactions

  • Jeffrey K. Aronson, Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK

Volume 25 in the series Side Effects of Drugs Annuals continues to serve the goal that is set for it: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading.

Special features of the current annual are

  • an essay by Dr Lara Marks, entitled 'The pill: untangling the adverse effects of a drug', invaluable for all workers in the field of Women's health and birth control, and
  • a review of the adverse effects of Anthracycline Antibiotics by Dr Fraser and Dr Twelves, published as part of the chapter on 'Cytostatics' by Dr Andrew Stanley.

Other important features of this Annual are the many special reviews. An index of Special Reviews is published in the book. The special reviews are short articles that deal in depth with a specific topic of current interest, typographically distinguished from the rest of the text, and marked by the prescription symbol of the eye of Horus. The current Annual is enriched with the infamous 'Drug Index' and 'Index of Adverse Drug Reactions'.Side Effects of Drugs Annual 25 is the second update of the encyclopaedic volume Meyler's Side Effects of Drugs, Fourteenth Edition, which was published in 2000.

View full description


Book information

  • Published: October 2002
  • Imprint: ELSEVIER
  • ISBN: 978-0-444-50674-0


...This is an excellent reference book for health sciences libraries and hospitals to include in their collections. This book is indispensable for pharmacists and prescribers.
P. Stachiw, E-Streams

Table of Contents

Cumulative Index of Special Reviews.
Essay: The pill: untangling the adverse reactions of a drug.
1. Central nervous system stimulants, drugs that suppress appetite, and drugs used in Alzheimer's disease (R.P. Sequeira).
2. Antidepressant drugs (P.J. Cowen).
3. Lithium (J.W. Jefferson).
4. Drugs of abuse (J.K. Patel, E. Wong, A.I. Green).
5. Hypnotics and sedatives (S. Curran, S. Musa).
6. Antipsychotic drugs (A. Carvajal, L.H. Martín Arias).
7. Antiepileptic drugs (J.K. Aronson).
8. Opioid analgesics and narcotic antagonists (A.H. Ghodse, A.M. Baldacchino).
9. Anti-inflammatory and antipyretic analgesics and drugs used in gout (A. Del Favero).
10. General anesthetics and therapeutic gases (T.G. Short, L. Nicholson).
11. Local anesthetics (S.A. Schug, M.C. Thornton).
12. Neuromuscular blocking agents and skeletal muscle relaxants (O. Zuzan, M. Leuwer).
13. Drugs affecting autonomic functions or the extrapyramidal system (M. Schachter).
14. Dermatological drugs, topical agents, and cosmetics (W.M.C. Mulder, M.M.H.M. Meinardi).
15. Antihistamines (J. Bousquet, P. Demoly).
16. Drugs acting on the respiratory tract (T.D. Robinson, A. Havryk, J.P. Seale).
17. Positive inotropic drugs and drugs used in dysrhythmias (J.K. Aronson).
18. Beta-adrenoceptor antagonists and antianginal drugs (A.P. Maggioni, M.G. Franzosi, R. Latini).
19. Drugs acting on the cerebral and peripheral circulations (R. Verhaeghe).
20. Antihypertensive drugs (F. Zannad).
21. Diuretics (D. Sica).
22. Metals (G.B. van der Voet, F.A. de Wolff).
23. Metal antagonists (R.H.B. Meyboom).
24. Antiseptic drugs and disinfectants (P. Magee).
25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines (T. Midtvedt).
26. Miscellaneous antibacterial drugs (A. Imhof, R. Walter).
27. Antifungal drugs (A.H. Groll, T.J. Walsh).
28. Antiprotozoal drugs (T. Planche, S. Krishna).
29. Antiviral drugs (D.J. Jeffries).
30. Drugs used in tuberculosis and leprosy (J.N. Pande).
31. Antihelminthic drugs (P.J.J. van Genderen).
32. Vaccines (S. Dittmann).
33. Blood, blood components, plasma and plasma products (H.W. Eijkhout, W.G. van Aken).
34. Intravenous infusions - solutions and emulsions (M.C. Allwood).
35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis (K. Peerlinck, J. Vermylen).
36. Gastrointestinal drugs (H.J. de Silva).
37. Drugs acting on the immune system (T.Vial, J. Descotes).
38. Vitamins (H.D. Reuter).
39. Corticotrophins, corticosteroids and prostaglandins (J. Costa, M. Farré).
40. Sex hormones and related compounds, including hormonal contraceptives (M.N.G. Dukes).
41. Thyroid hormones and antithyroid drugs (J.A. Franklyn).
42. Insulin, glucagon, and hypoglycemic drugs (H.M.J. Krans).
43. Miscellaneous hormones (P. Coates).
44. Drugs affecting lipid metabolism (I. Aursnes).
45. Cytostatic drugs (J. Fraser, C. Twelves, A. Stanley).
46. Radiological contrast agents (S.K. Morcos, B. Sundaram).
47. Drugs used in ocular treatment (B.C.P. Polak).
48. Treatments used in complementary medicine (E. Ernst).
49. Miscellaneous drugs, materials, and medical devices (N.H. Choulis).
50. The WHO International Drug Monitoring Programme (I.R. Edwards, S. Olsson).